trending Market Intelligence /marketintelligence/en/news-insights/trending/djgkkypzc0mz4jsco13ujq2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *

* Required

In this list

Golden Meditech to divest its stake in China Cord Blood for 5.76B yuan

AT&T To Use Wireless Subs To Create Buzz For HBO

Creating an Efficient Enterprise Wide Credit Risk Management System for a Leading Energy Company

Power and Gas M&A Symposium - 2019 Highlights

Financial Plumbing Prone To Clogging Amid Bank Liquidity Trap

Golden Meditech to divest its stake in China Cord Blood for 5.76B yuan

Golden Meditech Holdings Ltd. is selling the entirety of its holdings in China Cord Blood Corp. to Nanjing Yingpeng Huikang Medical Industry Investment Partnership for 5.76 billion Chinese yuan in cash.

The sale of the 65.4% stake will result in a "significant return to both the group and its shareholders," Golden Meditech said in a statement. The company plans to use the funds to consolidate its healthcare services platform while engaging in a strategic diversification.

Golden Meditech is guaranteeing performance at China Cord Blood and has agreed to make compensatory payments in case of an earnings shortfall.

As of Dec. 29, US$1 was equivalent to 6.95 yuan.